Trulieve Cannabis Corp.
Trulieve Cannabis Corp.
- Market cap
- $1.71B
Your view on TRLV
Overview
What the company does, where it operates, and who runs it.
About Trulieve Cannabis Corp.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kimberly A. Rivers
- Headquarters
- 3494 Martin Hurst Road, Tallahassee, FL, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kimberly A. Rivers
- Headquarters
- 3494 Martin Hurst Road, Tallahassee, FL, US
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery.
The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Trulieve Cannabis Corp.. Starting points for Trulieve Cannabis Corp.: EPS -$2.31, beta 1.92 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Trulieve Cannabis Corp.. Trailing twelve-month EPS for Trulieve Cannabis Corp. stands at -$2.31. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$15.00
average of analysts' targets
Analyst Ratings
- Strong Buy0
- Buy1
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2024 | Next QtrMar 2025 | Current YearFY Dec 2024 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | −$0.22 | −$0.07 | −$0.67 | −$0.43 |
| Low estimate | −$0.23 | −$0.08 | −$0.69 | −$0.44 |
| High estimate | −$0.22 | −$0.07 | −$0.66 | −$0.42 |
| No. of analysts | 1 | 1 | 1 | 2 |
| Year-ago EPS | — | — | — | — |
| Growth | — | — | — | — |
Revenue Estimate
| Revenue | Current QtrDec 2024 | Next QtrMar 2025 | Current YearFY Dec 2024 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | $292.49M | $294.28M | $1.18B | $1.19B |
| Low estimate | $288.16M | $289.92M | $1.17B | $1.18B |
| High estimate | $297.50M | $299.32M | $1.20B | $1.19B |
| No. of analysts | 4 | 3 | 3 | 2 |
| Year-ago revenue | — | — | — | — |
| Growth | — | — | — | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Trulieve Cannabis Corp.. Trulieve Cannabis Corp. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CANNTrees Corporation | Healthcare | OTC | $4.1M | ||
| CANQFCanaQuest Medical Corp. | Healthcare | OTC | $6.6M | ||
| CATV4Cable TV International, Inc. | Healthcare | OTC | $865,619 | ||
| CBDDCBD of Denver Inc. | Healthcare | OTC | $980,918 | ||
| CBDHFHempfusion Wellness Inc. | Healthcare | OTC | $1,635 | ||
| CBDLCBD Life Sciences Inc. | Healthcare | OTC | $375,394 | ||
| CBDXCurative Biosciences, Inc. | Healthcare | OTC | $51,578 | ||
| CBDYTarget Group Inc. | Healthcare | OTC | $863,836 | ||
| CBGLCannabis Global, Inc. | Healthcare | OTC | $28,410 | ||
| CBIHCannabis Bioscience International Holdings, Inc. | Healthcare | OTC | $5.2M | ||
| CBSTFThe Cannabist Company Holdings Inc. | Healthcare | NYSE | $14.5M | ||
| CBWTFAuxly Cannabis Group Inc. | Healthcare | OTC | $121.4M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| MSOSAdvisorShares Pure US Cannabis ETF | $793M in assets | 38.54% | |
| VXFVanguard Extended Market ETF | $30.2B in assets | 0.02% | |
| VTIVanguard Total Stock Market ETF | $689.2B in assets | 0.00% | |
| CNBSAmplify Seymour Cannabis ETF | $64M in assets | 16.79% | |
| SCHASchwab U.S. Small-Cap ETF | $21.7B in assets | 0.04% | |
| FYCFirst Trust Small Cap Growth AlphaDEX Fund | $1.4B in assets | 0.49% | |
| YOLOAdvisorShares Pure Cannabis ETF | $30M in assets | 16.50% | |
| FYXFirst Trust Small Cap Core AlphaDEX Fund | $1.4B in assets | 0.23% | |
Largest holders first, then the funds most concentrated in TRLV.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Trulieve Cannabis Corp., and how their positions are changing. At a $1.71B market value, institutional positions materially move Trulieve Cannabis Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Trulieve Cannabis Corp. executives and directors. Shares of Trulieve Cannabis Corp. have traded between $4.62 and $13.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Trulieve Cannabis Corp.. Coverage tracks Trulieve Cannabis Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Trulieve Cannabis Corp.